Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial

Trial ID or NCT#

NCT01756833

Status

not recruiting iconNOT RECRUITING

Purpose

The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison to a placebo-treated control group.

Official Title

Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT)

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Show Less

Investigator(s)

Ronald L. Dalman MD
Ronald L. Dalman MD
Vascular surgeon
Dr. Walter C. Chidester Professor

Contact us to find out if this trial is right for you.

Contact

Lori McDonnell
650-725-5227

View on ClinicalTrials.gov